+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2015-11-18Number of Pages: 82

Lateral Flow Diagnostic Tests Market - APAC Industry Analysis, Size, Share, Growth Trends and Forecast, 2015 - 2023

This report on the APAC lateral flow diagnostic tests market studies the current and future prospects of the global market. Lateral flow tests are performed to detect the presence of target analyte in the sample and are also known as lateral flow immunotechnology assays. Such tests are used for medical diagnostics either for home testing, point of care testing, or laboratory use. Growing incidences of infectious diseases, changing lifestyle of the APAC population and increasing government support is expected to accentuate the growth of lateral flow diagnostic tests market.

The APAC lateral flow diagnostic tests market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments and sub-segments of the market. It also provides information and data analysis of the APAC lateral flow diagnostic tests market with respect to market segments based on application and country analysis.

Based on application, the APAC lateral flow diagnostic tests market have been segmented into pregnancy, hepatitis, HIV, influenza, syphilis, malaria, and others which includes lung disorders, cardiac markers, drug abuse, etc. The market segments have been extensively analyzed based on usefulness, efficacy, revenue, and geographical coverage. The market size and forecast in terms of USD million for each segment has been provided for the period from 2013 to 2023. The report also provides the volume and compound annual growth rate (CAGR %) for each market segment for the forecast period from 2015 to 2023, considering 2013 and 2014 as the base years.

Geographically, the APAC lateral flow diagnostic tests market has been categorized into 14 major countries: China, India, South Korea, Indonesia, Australia, Japan, Malaysia, Philippines, Singapore, New Zealand, Vietnam, Bangladesh, Pakistan, and Rest of APAC. The market size and forecast for each of these regions has been provided for the period from 2013 to 2023, along with their respective CAGRs for the forecast period from 2015 to 2023. The research study also covers the competitive scenario in these regions. A detailed qualitative analysis of factors responsible for driving and restraining the growth of the market and future opportunities has been provided in the market overview section. This section of the report also provides Porter’s Five Forces analysis, and heat map analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the APAC lateral flow diagnostic tests market.

A list of recommendations has been provided for new entrants as well as existing market players to assist them in taking strategic initiatives to establish a strong presence in the market. The report also profiles major players in the APAC lateral flow diagnostic tests market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major players profiled in this report include Alere, Inc., Beckman Coulter, Inc., Becton, Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories, EMD Millipore, F. Hoffmann-La Roche Ltd., Siemens Healthcare, and  QIAGEN.

The APAC lateral flow diagnostic tests market is segmented as given below:

APAC Lateral Flow Diagnostic Tests Market, by Application, 2013-2023 (USD Miilion)

  • Pregnancy
  • Hepatitis
  • HIV
  • Influenza
  • Syphilis
  • Malaria
  • Others

APAC Lateral Flow Diagnostic Tests Market, by Country, 2013 – 2023 (USD Million)

  • China
  • India
  • South Korea
  • Indonesia
  • Australia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • New Zealand
  • Vietnam
  • Bangladesh
  • Pakistan
  • Rest of APAC

 

1. Preface
     1.1. Report Description
     1.2. Market Segmentation
     1.3. Research Methodology

2. Executive Summary
     2.1. APAC Lateral Flow Diagnostic Tests Market, Estimates and Forecast, By Revenue, 2013–2023 (US$ Mn)
     2.2. APAC Lateral Flow Diagnostic Tests Market, by Application, 2013-2023 (US$ Mn)
     2.3. APAC Lateral Flow Diagnostic Tests Market, by Country, 2013-2023 (US$ Mn)
     2.4. APAC Lateral Flow Diagnostic Tests Market Snapshot

3. APAC Lateral Flow Diagnostic Tests Market – Industry Analysis
     3.1. Market Overview
     3.2. Drivers
            3.2.1. Rapidly increasing health care cost
            3.2.2. Increasing demand for point-of-care diagnosis
     3.3. Restraints
            3.3.1. Frequent inaccurate results 
     3.4. Opportunities
            3.4.1. Untapped market for rapid diagnosis of cancer
     3.5. Porter’s Five Forces Analysis
     3.6. Heat Map Analysis: APAC Lateral Flow Diagnostic Test Market, by Key Players 

4. Market Segmentation – By Application
     4.1. Introduction
     4.2. APAC Lateral Flow Diagnostic Tests Market, by Application, 2013–2023 (US$ Mn)

5. APAC Lateral Flow Diagnostic Tests Market - Regional Analysis
     5.1. Japan Lateral Flow Diagnostic Tests Market Overview
     5.2. China Lateral Flow Diagnostic Tests Market Overview
     5.3. India Lateral Flow Diagnostic Tests Market Overview
     5.4. South Korea Lateral Flow Diagnostic Tests Market Overview
     5.5. Indonesia Lateral Flow Diagnostic Tests Market Overview
     5.6. Australia Lateral Flow Diagnostic Tests Market Overview
     5.7. Malaysia Lateral Flow Diagnostic Tests Market Overview
     5.8. Philippines Lateral Flow Diagnostic Tests Market Overview
     5.9. Singapore Lateral Flow Diagnostic Tests Market Overview
     5.10. New Zealand Lateral Flow Diagnostic Tests Market Overview
     5.11. Vietnam Lateral Flow Diagnostic Tests Market Overview
     5.12. Bangladesh Lateral Flow Diagnostic Tests Market Overview
     5.13. Pakistan Lateral Flow Diagnostic Tests Market Overview
     5.14. Rest of Asia Pacific Lateral Flow Diagnostic Tests Market Overview

6. Recommendations

7. Company Profiles.
     7.1. Alere, Inc., 
     7.2. Beckman Coulter, Inc.
     7.3. Becton, Dickinson and Company
     7.4. bioMérieux SA
     7.5. Bio-Rad Laboratories
     7.6. EMD Millipore
     7.7. F. Hoffmann-La Roche Ltd.
     7.8. Siemens Healthcare
     7.9. QIAGEN

Lateral flow tests are performed to detect the presence of target analyte in the sample and are also known as lateral flow immunotechnology assays. Such tests are used for medical diagnostics either for home testing, point of care testing, or laboratory use. The APAC lateral flow diagnostic tests market is expected to grow at a moderate rate due to rising prevalence of infectious diseases, increasing government initiatives and product innovation by various medical companies. 

Based on application, the APAC lateral flow diagnostic tests market has been segmented into pregnancy, hepatitis, HIV, influenza, syphilis, malaria, and other tests which include lung disorders, cardiac markers, drug abuse, etc. The pregnancy application segment dominated the APAC lateral flow diagnostic tests market accounting for the share of 26.4% in 2014. Increasing birth rate in Asia Pacific and easy-to-use tests kits are a few of the factors responsible for the high market share of pregnancy application segment. However, hepatitis application segment is expected to foresee the highest growth rate during the forecast period due to increasing prevalence of immunological disorders. In addition, the usage of lateral flow diagnostic test kits require minimal education for users and regulators, hence driving the growth of the hepatitis application segment in the near future. 

Geographically, Japan dominated the APAC lateral flow diagnostic tests market in 2014 with a share of 22.0% due to factors such as advancements in product designs and technologies and government initiatives related to awareness of infectious diseases among the people. Rising prevalence of life-threatening diseases and increasing birth rate are the other factors supporting the market growth in Japing. Indonesia is projected to be the most lucrative market for lateral flow diagnostic tests and is expected to expand at the highest growth rate of 9.2% from 2015 to 2023. Factors propelling the growth of the lateral flow diagnostic tests market in Indonesia are increasing number of population, an efficient healthcare system, and rising health care awareness among the people.

Major players in the APAC lateral flow diagnostic tests market include Alere, Inc., Beckman Coulter, Inc., Becton, Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories, EMD Millipore, F. Hoffmann-La Roche Ltd., Siemens Healthcare, and  QIAGEN. These players are involved in constant product development and competition with each other.

 

apac-lateral-flow-diagnostic-tests-market

 


A complete brochure for this research is available for download.

Interact with our pool of experienced analysts for any report related queries